| DC Field | Value | Language |
|---|
| dc.contributor.author | Agarkova, A. | - |
| dc.contributor.author | Pokrovskii, M. | - |
| dc.contributor.author | Kolesnichenko, P. | - |
| dc.contributor.author | Gureev, V. | - |
| dc.contributor.author | Gudyrev, O. | - |
| dc.contributor.author | Peresypkina, A. | - |
| dc.date.accessioned | 2021-11-23T11:59:44Z | - |
| dc.date.available | 2021-11-23T11:59:44Z | - |
| dc.date.issued | 2021 | - |
| dc.identifier.citation | Cerebroprotective effects of 2-ethyl-6-methyl-3-hydroxypyridine-2,6-dichlorophenyl(amino)phenylethanoic acid in the treatment of purulent meningitis / A. Agarkova [et al.] // Biomedicines. - 2021. - Vol.9, №3.-Art. 285. - Doi: 10.3390/biomedicines9030285. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/44314 | - |
| dc.description.abstract | The aim of the study was to evaluate the cerebroprotective effects of a new pharmacological compound 2-ethyl-6-methyl-3-hydroxypyridine-2,6-dichlorophenyl(amino)phenylethanoic acid (EMHDPA) on the bacterial purulent meningitis in a model of experimental pneumococcal meningitis | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | pneumococcal meningitis | ru |
| dc.subject | bacterial meningitis | ru |
| dc.subject | treatment | ru |
| dc.subject | cerebroprotection | ru |
| dc.subject | pharmacological compound | ru |
| dc.title | Cerebroprotective effects of 2-ethyl-6-methyl-3-hydroxypyridine-2,6-dichlorophenyl(amino)phenylethanoic acid in the treatment of purulent meningitis | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
